The MENA Biologics & Biosimilars Market will grow at highest pace owing to increasing healthcare expenditure
The MENA biologics and biosimilars market consists of large molecule drugs produced or extracted from living organisms used for the treatment of various chronic diseases. biologics help treat diseases such as cancer, diabetes, autoimmune disorders, etc. They are made from living cells and are often the only treatment option for life-threatening illnesses. Biosimilars provide more affordable...
0 Comments 0 Shares 641 Views 0 Reviews
Sponsored